ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years
Nicole Therville
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Mechanical compressive forces increase PI3K output signaling in breast and pancreatic cancer cells. Co-author DOI 10.26508/lsa.202402854↗
- Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance. Co-author DOI 10.1158/1535-7163.mct-20-0981↗
- Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. Co-author DOI 10.15252/emmm.202013502↗
- Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elasticity imaging. Co-author DOI 10.7150/thno.34066↗
- Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Co-author DOI 10.3390/cancers10060174↗
- Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter? Co-author DOI 10.1016/j.jbior.2015.05.001↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Julie Guillermet‐Guibert · 6 shared papers, 2015–2025 · strength 0.70
- Paper Mechanical compressive forces increase PI3K output signaling in breast and pancreatic cancer cells. DOI 10.26508/lsa.202402854↗
- Paper Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistan… DOI 10.1158/1535-7163.mct-20-0981↗
- Paper Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elas… DOI 10.7150/thno.34066↗
- Benoît Thibault · 4 shared papers, 2018–2025 · strength 0.53
- Paper Mechanical compressive forces increase PI3K output signaling in breast and pancreatic cancer cells. DOI 10.26508/lsa.202402854↗
- Paper Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistan… DOI 10.1158/1535-7163.mct-20-0981↗
- Paper Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. DOI 10.15252/emmm.202013502↗
- Célia Cintas · 4 shared papers, 2015–2021 · strength 0.36
- Paper Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistan… DOI 10.1158/1535-7163.mct-20-0981↗
- Paper Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. DOI 10.15252/emmm.202013502↗
- Paper Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. DOI 10.3390/cancers10060174↗
- Céline Basset · 3 shared papers, 2018–2021 · strength 0.28
- Paper Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elas… DOI 10.7150/thno.34066↗
- Paper Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. DOI 10.15252/emmm.202013502↗
- Paper Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. DOI 10.3390/cancers10060174↗
- Mickaël Di‐Luoffo · 1 shared paper, 2025 · strength 0.25
- Coralie Cayron · 2 shared papers, 2021 · strength 0.20
- Romain Baer · 2 shared papers, 2015–2021 · strength 0.17
- Zahra Dantes · 1 shared paper, 2021 · strength 0.10
- Paola Cappello · 1 shared paper, 2021 · strength 0.10
- Maximilian Reichert · 1 shared paper, 2021 · strength 0.10
- Fabrice Muscari · 1 shared paper, 2021 · strength 0.09
- Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09
- Gabriela Reyes‐Castellanos · 1 shared paper, 2021 · strength 0.09
- Pierre Cordelier · 1 shared paper, 2021 · strength 0.09
- Barbara Bournet · 1 shared paper, 2021 · strength 0.09
- Alice Carrier · 1 shared paper, 2021 · strength 0.09
- Dieter Saur · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.